Latest Financial Performance News

Complii FinTech Solutions reported a $1.35 million loss for H1 FY26 alongside a 6% increase in annual recurring revenue, driven by strategic platform upgrades and expanding client engagement.

FBR Limited reports a significant reduction in half-year losses alongside new robotic product launches, yet cash flow challenges raise questions about its financial sustainability.

Queste Communications Ltd (ASX:QUE) reported a modest company-level profit for H1 2025 but a consolidated loss driven by challenges in its associate investments, notably Bentley Capital Limited. The company’s financial performance remains closely tied to the share price movements of Strike Resources Limited.

Norwood Systems Limited reported a significant revenue increase for the half-year ended December 2025, alongside a widening net loss and strategic progress with Tier-1 telecom customers. The company secured additional funding and advanced its AI-driven voice platforms in collaboration with global hyperscalers.

KneoMedia Limited reported a half-year loss of $1.02 million for H1 FY26, impacted by delayed payments from New York City amid a mayoral transition. The company is preparing for ASX reinstatement and a $3 million capital raise to support growth.

Yojee Limited reported a 9% revenue increase driven by software activities, while net losses widened due to accelerated investment in its MOSAIC platform and joint venture costs. The company maintains a robust cash balance and has strengthened its leadership ahead of a mid-2026 commercial launch.

Mayfield Childcare Limited reported a modest revenue increase for 2025 but suffered a dramatic net loss and faced an audit qualification over related party disclosures.

Pure Foods Tasmania reports a $6.85 million half-year loss, driven by a strategic operational reset and loan covenant breach, while showing signs of stabilisation and margin improvement.

ClearVue Technologies reported a 9% reduced half-year loss of $5.25 million, while pushing forward with significant advancements in its solar glass technology and expanding global licensing partnerships.

Argent BioPharma reported a significantly reduced half-year loss of A$2.9 million, progressing a strategic acquisition to bolster its CannEpil drug pipeline and securing up to A$11 million in new funding.

SDI Limited reported a modest 2% dip in net profit for H1 FY26 despite a 2.7% rise in sales, driven by growth in aesthetics and exports. The company faces challenges from regulatory bans on Amalgam products while advancing plans for manufacturing upgrades and a potential acquisition.

Pointerra Limited reported a $2.14 million loss for the half-year ending December 2025 amid a 51% revenue decline, yet the company highlights promising contract wins and a growing recurring revenue base that could drive a turnaround in the second half.